ROIVANT SCIENCES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.03 USD | +1.38% |
|
+5.45% | -1.78% |
| 04-05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
| 04-04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
Chart calendar Roivant Sciences Ltd.
7c9cf83be75b23492cc7b1bef.eKH_47th1E44fltjIEwz3O3AIE5uHQByJnd0oF2so0g.MfigsNENrCUIFBwRdCMKjoWJdRsvXlE0X0UAjQ7NxDIb4L2u3QyiHktNAg~39cc90a55f4b78fd727f55304269be6d
Upcoming events on Roivant Sciences Ltd.
Past events on Roivant Sciences Ltd.
| 02/04/2024 13:00 | NEPTUNE Phase 2 Study Results Call |
| 11/03/2024 17:20 | Leerink Partners Global Biopharma Conference |
| 13/02/2024 13:00 | Q3 2023 Earnings Call |
| 13/02/2024 12:00 | Q3 2023 Earnings Release |
| 07/02/2024 19:30 | Guggenheim Healthcare Talks Biotechnology Conference |
| 08/01/2024 22:15 | JPMorgan Healthcare Conference |
| 30/11/2023 16:00 | Piper Sandler Healthcare Conference |
| 29/11/2023 17:55 | Evercore ISI HealthCONx Conference |
| 15/11/2023 13:30 | Jefferies London Healthcare Conference |
| 13/11/2023 13:00 | Q2 2023 Earnings Call |
| 13/11/2023 12:00 | Q2 2023 Earnings Release |
| 07/11/2023 21:30 | Guggenheim Inflammation, Neurology, & Immunology Conference |
| 23/10/2023 13:00 | Acquisition of Telavant Holdings, Inc by Roivant Sciences Ltd Call |
| 27/09/2023 16:30 | Cantor Global Healthcare Conference |
| 25/09/2023 | Investor Meeting |
| 12/09/2023 10:30 | Annual General Meeting |
| 11/09/2023 13:40 | Morgan Stanley Global Healthcare Conference |
| 07/09/2023 16:20 | Citi BioPharma Conference |
| 14/08/2023 13:00 | Q1 2023 Earnings Call |
| 14/08/2023 12:00 | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | March | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 55,3 52,6 5.08% | 61,3 52,3 17.2% | 655 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -1 346 -1 304 -3.16% | -1 156 -1 190 2.8% | -1 074 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -1 352 -1 181 -14.47% | -1 175 -1 170 -0.41% | 1 605 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -924 -864 -6.97% | -1 225 -1 313 6.71% | 4 170 |
|
Net income Million USD | Released Forecast Spread | -809 | -845 -740 -14.23% | -1 009 -1 216 16.99% | 4 253 |
|
EPS USD | Released Forecast Spread | -3,76 | -1,26 -1,24 -1.34% | -1,42 -1,71 17.02% | 5,18 |
| Announcement Date | 01/07/21 | 28/06/22 | 28/06/23 | - |
Quarterly results
| Fiscal Period | März | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 24,3 9,87 146.72% | 9,22 11,6 -20.3% | 4,32 7,18 -39.83% | 12,5 5,70 119.85% | 17,1 14,8 15.34% | 27,4 18,2 50.4% | 21,6 24,5 -11.69% | 37,1 27,1 36.82% | 37,1 29,8 24.53% | 31,9 | 48,8 | 35,3 | 39,1 | 45,0 |
|
EBITDA Million USD | Released Forecast Spread | -281 -291 3.52% | -378 -291 -29.92% | -228 -288 20.76% | -271 -284 4.56% | -271 -264 -2.5% | -282 -265 -6.51% | -240 | |||||||
|
EBIT Million USD | Released Forecast Spread | -246 -177 -38.73% | -267 -240 -10.95% | -282 -250 -13.14% | -281 -293 4.13% | -378 -309 -22.4% | -234 -285 17.76% | -276 -258 -7.28% | -276 -257 -7.63% | 5 061 -267 1992.11% | -284 | -250 | -282 | -296 | -299 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -306 -175 -75.31% | -291 -247 -17.8% | -350 -243 -43.86% | -314 -299 -5.05% | -382 -320 -19.46% | -179 -309 41.96% | -326 -249 -30.78% | -327 -249 -31.46% | 5 098 -279 1929.33% | -285 | -231 | -273 | -286 | -299 |
|
Net income Million USD | Released Forecast Spread | -285 -163 -74.87% | -270 -206 -30.98% | -332 -222 -49.66% | -292 -280 -4.2% | -352 -294 -19.63% | -33,6 -280 88.01% | -292 -235 -24.3% | -304 -225 -34.98% | 5 096 -255 2094.89% | -256 | -210 | -247 | -259 | -270 |
|
EPS USD | Released Forecast Spread | -0,41 -0,24 -70.83% | -0,39 -0,30 -30% | -0,48 -0,32 -48.02% | -0,42 -0,41 -1.76% | -0,49 -0,40 -22.69% | -0,05 -0,38 86.8% | -0,38 -0,31 -24.18% | -0,40 -0,31 -30.84% | 6,03 0,49 1140.1% | -0,30 | -0,33 | -0,34 | -0,36 | -0,36 |
| Announcement Date | 14/02/22 | 28/06/22 | 15/08/22 | 14/11/22 | 13/02/23 | 28/06/23 | 14/08/23 | 13/11/23 | 13/02/24 | - | - | - | - | - |
More events
Past sector events for Roivant Sciences Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ROIV Stock
- Calendar Roivant Sciences Ltd.
